{"BLL": {"Ticker": "BLL", "Company": "Ball Corp", "Sector": "Materials", "Updated": "2022-03-03", "Rating": [{"Date": "2022-03-03", "Rating": "Upgrade", "Organization": "BMO Capital Markets", "Rating_Change": "Market Perform to Outperform", "Target_Change": "$87 to $105"}, {"Date": "2022-01-20", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$110 to $100"}, {"Date": "2022-01-04", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Buy to Neutral", "Target_Change": "$105"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 3, "Period": "180 days", "Analists": ["Morgan Stanley", "BMO Capital Markets", "Citigroup"], "Price_Target": 103.33}, "BIIB": {"Ticker": "BIIB", "Company": "Biogen", "Sector": "Health Care", "Updated": "2022-03-03", "Rating": [{"Date": "2022-03-03", "Rating": "Upgrade", "Organization": "RBC Capital Mkts", "Rating_Change": "Sector Perform to Outperform", "Target_Change": "$227 to $248"}, {"Date": "2022-02-04", "Rating": "Reiterated", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform", "Target_Change": "$244 to $217"}, {"Date": "2022-02-04", "Rating": "Reiterated", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight", "Target_Change": "$284 to $235"}, {"Date": "2022-02-04", "Rating": "Reiterated", "Organization": "RBC Capital Mkts", "Rating_Change": "Sector Perform", "Target_Change": "$225 to $227"}, {"Date": "2022-02-04", "Rating": "Reiterated", "Organization": "Oppenheimer", "Rating_Change": "Outperform", "Target_Change": "$350 to $285"}, {"Date": "2022-02-04", "Rating": "Reiterated", "Organization": "Needham", "Rating_Change": "Buy", "Target_Change": "$292 to $290"}, {"Date": "2022-02-04", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$245 to $230"}, {"Date": "2022-02-04", "Rating": "Reiterated", "Organization": "Barclays", "Rating_Change": "Equal Weight", "Target_Change": "$244 to $235"}, {"Date": "2022-02-04", "Rating": "Downgrade", "Organization": "BMO Capital Markets", "Rating_Change": "Outperform to Market Perform", "Target_Change": "$260 to $238"}, {"Date": "2022-02-04", "Rating": "Reiterated", "Organization": "Wedbush", "Rating_Change": "Neutral", "Target_Change": "$195 to $185"}, {"Date": "2022-02-04", "Rating": "Reiterated", "Organization": "Robert W. Baird", "Rating_Change": "Neutral", "Target_Change": "$258 to $224"}, {"Date": "2022-02-04", "Rating": "Reiterated", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$360 to $330"}, {"Date": "2022-02-04", "Rating": "Reiterated", "Organization": "Cowen", "Rating_Change": "Outperform", "Target_Change": "$375 to $285"}, {"Date": "2022-01-13", "Rating": "Downgrade", "Organization": "Guggenheim", "Rating_Change": "Buy to Neutral", "Target_Change": "$290 to $202"}, {"Date": "2022-01-12", "Rating": "Downgrade", "Organization": "Piper Sandler", "Rating_Change": "Overweight to Neutral", "Target_Change": "$362 to $216"}, {"Date": "2021-12-10", "Rating": "Resumed", "Organization": "Raymond James", "Rating_Change": "Mkt Perform", "Target_Change": ""}, {"Date": "2021-12-09", "Rating": "Resumed", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight", "Target_Change": "$250"}, {"Date": "2021-12-06", "Rating": "Initiated", "Organization": "Goldman", "Rating_Change": "Neutral", "Target_Change": "$271"}], "Score": 0.22, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 18, "Period": "180 days", "Analists": ["BofA Securities", "Wolfe Research", "BMO Capital Markets", "Guggenheim", "Needham", "Wedbush", "Barclays", "Robert W. Baird", "Goldman", "Oppenheimer", "Wells Fargo", "Raymond James", "Piper Sandler", "RBC Capital Mkts", "Morgan Stanley", "Cowen"], "Price_Target": 230.56}, "BXP": {"Ticker": "BXP", "Company": "Boston Properties", "Sector": "Real Estate", "Updated": "2022-03-03", "Rating": [{"Date": "2022-03-03", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "Outperform to In-line", "Target_Change": "$129"}, {"Date": "2022-01-07", "Rating": "Upgrade", "Organization": "BMO Capital Markets", "Rating_Change": "Market Perform to Outperform", "Target_Change": "$125 to $140"}, {"Date": "2022-01-03", "Rating": "Upgrade", "Organization": "Deutsche Bank", "Rating_Change": "Hold to Buy", "Target_Change": "$131"}, {"Date": "2021-12-06", "Rating": "Upgrade", "Organization": "Evercore ISI", "Rating_Change": "In-line to Outperform", "Target_Change": ""}], "Score": 0.5, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 4, "Period": "180 days", "Analists": ["Deutsche Bank", "BMO Capital Markets", "Evercore ISI"], "Price_Target": 99.0}, "CVX": {"Ticker": "CVX", "Company": "Chevron Corporation", "Sector": "Energy", "Updated": "2022-03-03", "Rating": [{"Date": "2022-03-03", "Rating": "Reiterated", "Organization": "Cowen", "Rating_Change": "Outperform", "Target_Change": "$140 to $160"}, {"Date": "2022-03-02", "Rating": "Upgrade", "Organization": "DZ Bank", "Rating_Change": "Hold to Buy", "Target_Change": "$167"}, {"Date": "2022-02-23", "Rating": "Reiterated", "Organization": "Cowen", "Rating_Change": "Outperform", "Target_Change": "$133 to $140"}, {"Date": "2022-01-31", "Rating": "Reiterated", "Organization": "Goldman", "Rating_Change": "Neutral", "Target_Change": "$146 to $142"}, {"Date": "2022-01-31", "Rating": "Reiterated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$140 to $145"}, {"Date": "2022-01-31", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Buy", "Target_Change": "$150 to $154"}, {"Date": "2022-01-31", "Rating": "Downgrade", "Organization": "Truist", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2022-01-05", "Rating": "Upgrade", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight to Overweight", "Target_Change": ""}], "Score": 1.12, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 8, "Period": "180 days", "Analists": ["BofA Securities", "Truist", "DZ Bank", "Goldman", "Wells Fargo", "Credit Suisse", "Cowen"], "Price_Target": 111.5}, "C": {"Ticker": "C", "Company": "Citigroup", "Sector": "Financials", "Updated": "2022-03-03", "Rating": [{"Date": "2022-03-03", "Rating": "Downgrade", "Organization": "Keefe Bruyette", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": "$81 to $64"}, {"Date": "2022-03-03", "Rating": "Downgrade", "Organization": "Atlantic Equities", "Rating_Change": "Overweight to Neutral", "Target_Change": "$70"}, {"Date": "2021-12-15", "Rating": "Upgrade", "Organization": "Odeon", "Rating_Change": "Hold to Buy", "Target_Change": "$69.25"}, {"Date": "2021-12-10", "Rating": "Resumed", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$67"}, {"Date": "2021-12-06", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$82"}], "Score": -0.8, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 5, "Period": "180 days", "Analists": ["UBS", "Keefe Bruyette", "Morgan Stanley", "Odeon", "Atlantic Equities"], "Price_Target": 55.6}, "INTC": {"Ticker": "INTC", "Company": "Intel", "Sector": "Information Technology", "Updated": "2022-03-03", "Rating": [{"Date": "2022-03-03", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight to Underweight", "Target_Change": "$55 to $47"}, {"Date": "2022-02-24", "Rating": "Downgrade", "Organization": "DZ Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$48"}, {"Date": "2022-02-23", "Rating": "Upgrade", "Organization": "Raymond James", "Rating_Change": "Underperform to Mkt Perform", "Target_Change": ""}, {"Date": "2022-01-27", "Rating": "Reiterated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$58 to $53"}, {"Date": "2022-01-27", "Rating": "Reiterated", "Organization": "Mizuho", "Rating_Change": "Neutral", "Target_Change": "$55 to $53"}, {"Date": "2022-01-27", "Rating": "Reiterated", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$80 to $70"}, {"Date": "2022-01-27", "Rating": "Reiterated", "Organization": "Citigroup", "Rating_Change": "Neutral", "Target_Change": "$58 to $55"}, {"Date": "2022-01-27", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Underperform", "Target_Change": "$55 to $52"}, {"Date": "2022-01-18", "Rating": "Reiterated", "Organization": "Citigroup", "Rating_Change": "Neutral", "Target_Change": "$52 to $58"}, {"Date": "2022-01-12", "Rating": "Reiterated", "Organization": "Barclays", "Rating_Change": "Underweight", "Target_Change": "$45 to $50"}, {"Date": "2022-01-11", "Rating": "Downgrade", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Overweight to Sector Weight", "Target_Change": ""}, {"Date": "2022-01-10", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Underperform", "Target_Change": "$50 to $55"}, {"Date": "2022-01-05", "Rating": "Upgrade", "Organization": "Northland Capital", "Rating_Change": "Market Perform to Outperform", "Target_Change": "$62"}], "Score": -0.23, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 13, "Period": "180 days", "Analists": ["KeyBanc Capital Markets", "BofA Securities", "Citigroup", "Northland Capital", "Barclays", "DZ Bank", "Mizuho", "Raymond James", "UBS", "Morgan Stanley", "Credit Suisse"], "Price_Target": 44.38}, "LIN": {"Ticker": "LIN", "Company": "Linde", "Sector": "Materials", "Updated": "2022-03-03", "Rating": [{"Date": "2022-03-03", "Rating": "Reiterated", "Organization": "Cowen", "Rating_Change": "Market Perform", "Target_Change": "$345 to $330"}, {"Date": "2021-12-09", "Rating": "Upgrade", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform to Outperform", "Target_Change": "$338 to $404"}, {"Date": "2021-12-07", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "Outperform to In-line", "Target_Change": ""}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 3, "Period": "180 days", "Analists": ["Wolfe Research", "Cowen", "Evercore ISI"], "Price_Target": 243.67}, "QRVO": {"Ticker": "QRVO", "Company": "Qorvo", "Sector": "Information Technology", "Updated": "2022-03-03", "Rating": [{"Date": "2022-03-03", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$185 to $150"}, {"Date": "2022-02-03", "Rating": "Reiterated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$180 to $145"}, {"Date": "2022-02-03", "Rating": "Reiterated", "Organization": "The Benchmark Company", "Rating_Change": "Buy", "Target_Change": "$225 to $175"}, {"Date": "2022-02-03", "Rating": "Reiterated", "Organization": "Rosenblatt", "Rating_Change": "Neutral", "Target_Change": "$190 to $170"}, {"Date": "2022-02-03", "Rating": "Reiterated", "Organization": "Piper Sandler", "Rating_Change": "Overweight", "Target_Change": "$200 to $190"}, {"Date": "2022-02-03", "Rating": "Reiterated", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$208 to $185"}, {"Date": "2022-02-03", "Rating": "Reiterated", "Organization": "Mizuho", "Rating_Change": "Neutral", "Target_Change": "$170 to $155"}, {"Date": "2022-02-03", "Rating": "Reiterated", "Organization": "Cowen", "Rating_Change": "Outperform", "Target_Change": "$230 to $195"}, {"Date": "2022-02-03", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$180 to $165"}, {"Date": "2022-02-03", "Rating": "Reiterated", "Organization": "BMO Capital Markets", "Rating_Change": "Market Perform", "Target_Change": "$185 to $160"}, {"Date": "2022-02-03", "Rating": "Reiterated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$220 to $200"}, {"Date": "2022-01-13", "Rating": "Downgrade", "Organization": "Oppenheimer", "Rating_Change": "Outperform to Perform", "Target_Change": ""}, {"Date": "2022-01-10", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$190 to $180"}], "Score": 0.62, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 13, "Period": "180 days", "Analists": ["The Benchmark Company", "BofA Securities", "BMO Capital Markets", "Rosenblatt", "Barclays", "Mizuho", "Oppenheimer", "Piper Sandler", "UBS", "Morgan Stanley", "Cowen"], "Price_Target": 158.23}, "LUV": {"Ticker": "LUV", "Company": "Southwest Airlines", "Sector": "Industrials", "Updated": "2022-03-03", "Rating": [{"Date": "2022-03-03", "Rating": "Upgrade", "Organization": "Evercore ISI", "Rating_Change": "In-line to Outperform", "Target_Change": "$48"}, {"Date": "2022-02-15", "Rating": "Resumed", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform", "Target_Change": ""}, {"Date": "2022-01-13", "Rating": "Downgrade", "Organization": "Susquehanna", "Rating_Change": "Positive to Neutral", "Target_Change": "$52 to $50"}, {"Date": "2022-01-12", "Rating": "Downgrade", "Organization": "Wolfe Research", "Rating_Change": "Outperform to Peer Perform", "Target_Change": ""}, {"Date": "2022-01-03", "Rating": "Downgrade", "Organization": "MKM Partners", "Rating_Change": "Buy to Neutral", "Target_Change": "$45"}, {"Date": "2021-12-15", "Rating": "Reiterated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$75 to $65"}, {"Date": "2021-12-10", "Rating": "Downgrade", "Organization": "Goldman", "Rating_Change": "Neutral to Sell", "Target_Change": "$59 to $36"}, {"Date": "2021-12-09", "Rating": "Downgrade", "Organization": "UBS", "Rating_Change": "Buy to Neutral", "Target_Change": ""}, {"Date": "2021-12-09", "Rating": "Downgrade", "Organization": "Jefferies", "Rating_Change": "Buy to Hold", "Target_Change": "$60 to $45"}], "Score": -0.56, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 9, "Period": "180 days", "Analists": ["Jefferies", "Wolfe Research", "Evercore ISI", "Susquehanna", "Barclays", "Goldman", "MKM Partners", "UBS"], "Price_Target": 29.11}, "TER": {"Ticker": "TER", "Company": "Teradyne", "Sector": "Information Technology", "Updated": "2022-03-03", "Rating": [{"Date": "2022-03-03", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$132"}, {"Date": "2022-01-28", "Rating": "Upgrade", "Organization": "Craig Hallum", "Rating_Change": "Hold to Buy", "Target_Change": "$138"}, {"Date": "2022-01-28", "Rating": "Downgrade", "Organization": "Stifel", "Rating_Change": "Buy to Hold", "Target_Change": "$160 to $115"}, {"Date": "2022-01-28", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$170 to $120"}, {"Date": "2022-01-27", "Rating": "Reiterated", "Organization": "Cowen", "Rating_Change": "Outperform", "Target_Change": "$180 to $160"}, {"Date": "2022-01-26", "Rating": "Initiated", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Overweight", "Target_Change": "$180"}, {"Date": "2022-01-14", "Rating": "Initiated", "Organization": "Loop Capital", "Rating_Change": "Buy", "Target_Change": "$202"}, {"Date": "2022-01-10", "Rating": "Reiterated", "Organization": "BofA Securities", "Rating_Change": "Buy", "Target_Change": "$175 to $205"}, {"Date": "2021-12-15", "Rating": "Reiterated", "Organization": "Piper Sandler", "Rating_Change": "Overweight", "Target_Change": "$172 to $173"}, {"Date": "2021-12-15", "Rating": "Reiterated", "Organization": "Deutsche Bank", "Rating_Change": "Buy", "Target_Change": "$150 to $170"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 10, "Period": "180 days", "Analists": ["KeyBanc Capital Markets", "BofA Securities", "Craig Hallum", "Deutsche Bank", "Loop Capital", "Piper Sandler", "Morgan Stanley", "Stifel", "Cowen"], "Price_Target": 159.5}}